6',6''-Di(pyridin-2-yl)-2,2':4',4'':2'',2'''-quaterpyridine200mg

Monocarboxydecyl terminated polydimethylsiloxane, asymmetric, 20 cSt, 100g

3-Bromo-2-iodoaniline, 97.0%, 250mg

4-Oxo-4-((3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)amino)butanoic acid, 95.0%, 250mg

TRIS hydrochloride, 1 kg

(2S,3R,4S,5R)-2,3,4,5-Tetrahydroxy-6-oxohexanoic acid hydrate, 95.0%, 5g

(S)-1-Boc-2-butyl-piperazine, 97%, 10g

2,4-Dichloro-5-(chloromethyl)pyridine, 95.0%, 250mg

Benzyl L-(+)-Mandelate>98.0%(GC)5g

1-Acetylpiperidine-4-carboxylic acid, 98.0%, 25g

CHAPS 10% solution, sterile-filtered, 25g

3-Cyclopentyl-3-oxopropanenitrile, 95.0%, 5g

p-Toluenesulfonyl isocyanate, 95.0%, 25g